Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-13

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To comparative pain intensity, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with post-COVID-19 and without post-COVID-19 was aimed in current study. Knowledge in the literature regarding this topic is still obscure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Non-motor Symptoms, Balance, Muscle Strength, and Functional Mobility in Patients With Parkinson's Disease

NCT04420910

Parkinson Disease Balance Muscle Strength +2 more

COMPLETED

The Effect of Proprioceptive Neuromuscular Facilitation on Trunk Mobility, Gait, Fear of Falling, and Quality of Life in Individuals Diagnosed With Parkinson's Disease

NCT07327645

PARKINSON DISEASE (Disorder) Proprioceptive Neuromuscular Facilitation Fear of Falling +3 more

COMPLETED NA

Effect of Sensorimotor Training on Upper Extremity in Parkinson's Patients

NCT05241015

Parkinson Disease

COMPLETED NA

Effects of Home-based High-speed Bodyweight Resistance Training in Individual with Parkinson's Disease

NCT06646523

Parkinson Disease

RECRUITING NA

Effects of Telerehabilitation-Based Motor and Cognitive Dual-Task Exercise in Patients With Parkinson's Disease

NCT05894473

Parkinson Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute worsening and long-term sequelae of motor and non-motor symptoms have also been described in Parkinson's patients during and after SARS-CoV-2 infection, which is also known as prolonged COVID. The effects of COVID-19 on pain, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients are still unclear today. For this reason, in this study, it was aimed to comparatively investigate pain, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with COVID-19 and without COVID-19 and to show the relationships between these outcome measures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Respiratory Infection Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Post-COVID-19 group

This group will consist of individuals with Parkinson disease who have had COVID-19.

Physical Evaluations of post-COVID-19 individuals

Intervention Type OTHER

In this research, the data of Parkinson's patients who have had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

Control group

The control group will consist of individuals with Parkinson disease without post-COVID-19.

Physical Evaluations of non-post-COVID-19 individuals

Intervention Type OTHER

In this research, the data of Parkinson's patients who have not had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical Evaluations of post-COVID-19 individuals

In this research, the data of Parkinson's patients who have had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

Intervention Type OTHER

Physical Evaluations of non-post-COVID-19 individuals

In this research, the data of Parkinson's patients who have not had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with COVID-19 at least 12 weeks ago and recovered,
* Being over 18 years old,
* Volunteering to participate in the research,
* Being diagnosed with Parkinson's disease
* Comorbid conditions (such as hypertension, diabetes) are under control
* Being able to perceive assessments (Standardized Mini Mental Test score of 24 and above)
* Having the ability to ambulate and walk independently
* Being in stage 1 - 4 according to the Modified Hoehn-Yahr Scale

* Not being diagnosed or suspected of COVID-19
* Being over 18 years old,
* Volunteering to participate in the research,
* Being diagnosed with Parkinson's disease
* Having comorbid conditions (such as hypertension, diabetes) which are under control
* Being able to perceive assessments (Standardized Mini Mental Test score of 24 and above)
* Having the ability to ambulate and walk independently
* Being in stage 1 - 4 according to the Modified Hoehn-Yahr Scale

Exclusion Criteria

* Sudden drug or dose change during the study period
* A history of any acute/chronic orthopedic, cardiovascular, pulmonary, psychiatric or neuromuscular disease that may prevent measurements from being made.
* Having had myocardial infarction and pulmonary embolism in the last 30 days,
* Having a history of additional neurological (stroke, head trauma, peripheral nerve diseases, brain and spinal cord tumors, etc.) diseases other than Parkinson's disease
* Having severe vision loss or vestibular dysfunction
* Patients with blood pressure values above 140/90 and below 90/50 in blood pressure measurements made before the study, with arrhythmia on ECG, with a history of shortness of breath and/or palpitation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No